YAP1 and pancreatic ductal adenocarcinoma: A recent study identified an extracellular vesicle-based network (EV-Net) that was comprised of proteoglycan Agrin-enriched stem cells that effectively activated YAP to promote pancreatic ductal adenocarcinomas via lipo-protein-related receptor-4 (Lrp4) [159].